Electromechanical Coupling Alterations in Diabetic Cardiomyopathy: A Translational Approach

Background: Diabetic cardiomyopathy (DCM) is a distinct clinical entity characterized by myocardial dysfunction in the absence of overt coronary artery disease or hypertension. It contributes significantly to heart failure incidence in patients with type 2 diabetes mellitus. While metabolic and structural abnormalities are well recognized in DCM, emerging evidence suggests that altered electromechanical coupling—defined as the integration of electrical excitation with mechanical contraction—plays a pivotal role in disease progression. Understanding the mechanisms underlying these impairments is essential for identifying novel therapeutic targets and improving outcomes in diabetic populations. Methods and Results: This review synthesizes findings from preclinical models, human tissue studies, and clinical investigations exploring the electromechanical derangements in DCM. At the cellular level, prolonged action potential duration, impaired calcium reuptake, and sarcoplasmic reticulum leak contribute to delayed relaxation and contractile dysfunction. Ion channel remodeling, particularly of K⁺ and Ca²⁺ channels, leads to electrical instability and increased arrhythmia susceptibility. Simultaneously, fibrosis and altered gap junction expression (notably connexin-43 downregulation) disrupt myocardial conduction and mechanical synchrony. Imaging modalities such as tissue Doppler imaging, speckle tracking echocardiography, and cardiac MRI with tagging have revealed early abnormalities in strain, strain rate, and mechanical dispersion even before ejection fraction declines. Translational studies using induced pluripotent stem cell–derived cardiomyocytes and diabetic animal models provide mechanistic insights and platforms for drug testing. Therapies targeting electromechanical integration—including late sodium current inhibitors, SERCA2a modulators, and anti-fibrotic agents—are under investigation to restore synchrony and improve cardiac performance. Conclusion: Electromechanical coupling abnormalities are central to the pathophysiology of diabetic cardiomyopathy and represent a promising frontier for early diagnosis and targeted intervention.